C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
10/2001
10/30/2001	US6310081 Protein tyrosine phosphatase inhibitors
10/30/2001	US6310080 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
10/30/2001	US6310074 Substituted dimeric compounds
10/30/2001	US6310052 Nitrate esters and their use for neurological conditions
10/30/2001	CA2123101C Nitroxyalkylamide derivative
10/25/2001	WO2001079478A1 Factors participating in degranulation of mast cells, dnas encoding the same, method of screening inhibitors of these factors and the inhibitors
10/25/2001	WO2001079192A1 Process for preparing 5-substituted-2(5h)-furanones
10/25/2001	WO2001079164A2 N-substituted dithiocarbamates for the treatment of biological disorders
10/25/2001	WO2001079157A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001	WO2001078733A1 Alpha,beta-unsaturated sulfones for treating proliferative disorders
10/25/2001	WO2001078723A1 Compounds and methods
10/25/2001	WO2001078720A1 Decreasing the intracellular level of beta-catenin by administering hydroxymatairesinol
10/25/2001	WO2001041924A3 Oxidative reactions using membranes that selectively conduct oxygen
10/25/2001	WO2001028987A8 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/25/2001	WO2001021605A3 Method for extracting compounds of furan lipids and polyhydroxylated fatty alcohols of avocado, composition based on said compounds and use of said compounds in therapy, cosmetics and food
10/25/2001	US20010034454 Description anti-mitotic agents which inhibit tubulin polymerization
10/25/2001	US20010034447 N-(5-tert-butyl-2-methoxyphenyl)-n'-(4-(1-oxoisoindolin-5-ylox y)penyl)urea as anticarcinogenic agents
10/25/2001	US20010034341 Bactericides
10/25/2001	CA2406442A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001	CA2406023A1 Decreasing the intracellular level of beta-catenin by administering hydroxymatairesinol
10/25/2001	CA2403490A1 N-substituted dithiocarbamates for the treatment of biological disorders
10/24/2001	EP1148048A2 Polyaromatic antiviral compositions
10/24/2001	EP1147101A1 Reverse hydroxamate inhibitors of matrix metalloproteinases
10/24/2001	EP0840717B1 Preparation of aldehydes or ketones from alcohols
10/24/2001	EP0707575B1 Use of dihydrobenzofuranones as scenting ingredients
10/24/2001	CN1319092A Benzamide derivatives and their use as cytokine inhibitors
10/24/2001	CN1319088A Arylsulfonanilide ureas
10/24/2001	CN1319086A Anthranilic acid derivatives
10/24/2001	CN1319011A Tumor tissue accumulation enhancers for drugs
10/24/2001	CN1319007A Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
10/24/2001	CN1318544A Inhibitor used as antioxygen and 5-lipoxygenase, and anti-inflammatory non-steroid carboxylic ester and amide of non-steroid anti-inflammatory agent
10/24/2001	CN1318543A Pre-rectification treatment of crude chlorobenzoic anhydride and chlorophthalic acid product
10/24/2001	CN1318535A Dihalopropene compound, insecticide/miticide containing the same and intermediate for producing the same
10/24/2001	CN1073551C Ethenyl amide compound prodn process
10/23/2001	US6307087 Ligands for metals and improved metal-catalyzed processes based thereon
10/23/2001	US6307070 Fungicides
10/23/2001	US6307067 Palladium and boron co-catalyzed addition of oxygen nucleophiles to vinyl epoxides
10/23/2001	US6307057 Catalyze enantioselective reactions, e.g., diels-alder reactions
10/23/2001	US6307051 2-alkylidene hydroxycoumaranone derivatives
10/23/2001	US6306899 Viricides
10/23/2001	US6306895 Substituted oxygen alicyclic compounds, including methods for synthesis thereof
10/23/2001	US6306892 Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
10/23/2001	US6306887 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
10/23/2001	US6306881 Anti-inflammatory agents
10/23/2001	US6306857 Methods for treating or preventing alzheimer's disease using substituted 1-aryl-3-piperazin-1′-yl propanones
10/23/2001	CA2049368C Treatment of cerebro-vascular disorders
10/18/2001	WO2001077359A2 Preparation of thiols and derivatives by bio-conversion
10/18/2001	WO2001077096A2 Preparation of natural thioacetates and derivatives
10/18/2001	WO2001077095A2 Derivatives of alpha-mercaptoacetamide
10/18/2001	WO2001077074A1 Process for preparing optically active aminopentane derivatives
10/18/2001	WO2001038316A3 Sulfonyl oxazole amines and their use as 5-ht6 receptor ligands
10/18/2001	WO2001002383A8 Process for the synthesis of citalopram
10/18/2001	US20010031874 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
10/18/2001	US20010031784 Antidepressants; simplification
10/18/2001	US20010031779 Methods and materials for treating and preventing inflammation of mucosal tissue
10/18/2001	US20010031766 Prostaglandin receptor ligands
10/18/2001	US20010031757 Administering compounds such as 3-(2-phenylethylamino)-6-methyl-1-(2-amino-6-methyl-5-methylene -carboxamidomethylpyridi nyl)-2-pyrazinone, N'-((1-(Aminoiminomethyl)4-piperidinyl) methyl)-N-(3,3- diphenylpropionyl)-L-proline amide
10/18/2001	DE10108042A1 Crystalline citalopram base and salts with high purity useful for treatment of depression
10/17/2001	EP1146041A1 Derivatives of heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane and their use as inhibitors of the recapture of serotonine and of noradrenaline
10/17/2001	EP1146032A1 Process for the production of alkanediol derivatives
10/17/2001	EP1145710A1 Use of ascorbic acid derivatives for increasing epidermal ceramides synthesis
10/17/2001	EP1144400A1 Production of aqueous solutions of mixtures of formyltetrahydrofuran and hydrates thereof
10/17/2001	EP1144399A2 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
10/17/2001	EP1144397A2 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
10/17/2001	EP1144375A2 Synthesis of oligoketides
10/17/2001	EP1144365A2 Inhibitors of alpha-4 beta-1 mediated cell adhesion
10/17/2001	EP1144354A1 Anhydride stabilization
10/17/2001	EP1143965A1 Carbocyclic potassium channel inhibitors
10/17/2001	EP1143959A2 Antifungal activity of dicationic molecules
10/17/2001	CN1318062A Method for producing tetrahydrofuran
10/17/2001	CN1073102C New 4-(1-piperazinyl) benzoic acid derivatives, process for preparing them and their therapeutic applications
10/17/2001	CN1073074C Process for oxidation of primary or secondary alcohols
10/16/2001	US6303816 N-2-(4-(4-(2-methanesulfonamidoethyl)phenyl)phenyl)-propyl 2-propanesulfonamide or a pharmaceutically acceptable salt thereof.
10/16/2001	US6303789 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors
10/16/2001	US6303658 Therapy of ocular hypertension by applying cyclopentane heptenoic acid or heptanoic acid and/or derivative
10/16/2001	US6303611 For therapy of hyperalgesis
10/16/2001	US6302958 Sonic impinging jet crystallization apparatus and process
10/16/2001	CA2025301C New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase
10/11/2001	WO2001074910A2 Ether-amine based polymerization catalysts, compositions and processes using same
10/11/2001	WO2001074820A1 Novel derivatives and analogues of galanthamin
10/11/2001	WO2001074805A1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
10/11/2001	WO2001074801A1 Immunosuppressant n-acyles homoserine lactones
10/11/2001	WO2001074780A1 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist
10/11/2001	WO2001074770A1 C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides
10/11/2001	WO2001074763A1 Aryl and heteroaryl sulfonates
10/11/2001	WO2001074753A1 Synthetic derivatives of lunularic acid, medicaments containing said compounds, method for producing the lunularic acid derivatives and the use thereof
10/11/2001	WO2001074506A1 Extrusion die
10/11/2001	WO2000050376A9 Efficient synthesis of alkyl carbonates
10/11/2001	WO2000017176A3 Benzoylguanidine derivatives with advantageous properties, method for producing them and their use in the production of medicaments
10/11/2001	US20010029304 Cyclopentane heptan (ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
10/11/2001	US20010029302 Catalytic hydrogenation using palladium, molybdenum, nickelcatalyst
10/11/2001	US20010029265 Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
10/11/2001	DE10016544A1 New phenyl-substituted cyclic keto-enol compounds useful e.g. as insecticides, acaricides, nematocides, acaricides, herbicides, ectoparasiticides, antifouling agents or intermediates
10/11/2001	DE10015866A1 Aryl- und Heteroarylsulfonate Aryl and Heteroarylsulfonate
10/11/2001	DE10015525A1 Synthetische Derivate von Lunularsäure, Arzneimittel enthaltend diese Verbindung, Verfahren zur Herstellung der Lunularsäurederivate sowie deren Verwendung Synthetic derivatives of Lunularsäure, to medicaments containing this compound, methods of making them and their use of the Lunularsäurederivate
10/11/2001	CA2829534A1 C2-phenyl-substituted cyclic keto-enols as pesticides and herbicides
10/11/2001	CA2404868A1 C2-phenyl-substituted cyclic keto-enols as pesticides and herbicides
10/11/2001	CA2404545A1 Aryl and heteroaryl sulfonates
10/11/2001	CA2403885A1 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist
10/11/2001	CA2402705A1 Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain

1 ... 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 ... 472